Company JanOne Inc.

Equities

JAN

US47089W1045

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 18/05/2024 am IST			5-day change	1st Jan Change
3.39 ^USD	-2.87%		-15.46%	+510.81%

16/05	JanOne Closes Acquisition of Blockchain Fintech Firm -- Shares Fall After Hours	MT
16/05	JanOne Inc. completed the acquisition of Alt 5 Sigma Inc.	CI

JanOne Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, acquiring, licensing, developing, partnering, and commercializing novel, no-opioid, and non-addictive therapies to address the large, unmet medical need for the treatment of pain and addiction. Its drug candidate, JAN101, is a patented oral, sustained-release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities, such as those with vascular complications of diabetes or Peripheral Artery Disease (PAD) and treats pain. Its drug candidate is a treatment for Peripheral Artery Disease. The Company operates through the Biotechnology segment, which is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Company is also engaged in providing blockchain-powered technologies through its two platforms: ALT 5 Pay and ALT 5 Prime.

Number of employees: 5

Managers	Title	Age	Since
Antonios Isaac CEO	Chief Executive Officer	71	01/15/01
Virland Johnson DFI	Director of Finance/CFO	64	21/17/21
Amol Soin CTO	Chief Tech/Sci/R&D Officer	-	29/20/29
Anthony Giordano CTO	Chief Tech/Sci/R&D Officer	-	03/19/03

Members of the board	Title	Age	Since
Antonios Isaac CEO	Chief Executive Officer	71	01/15/01
Richard Butler BRD	Director/Board Member	74	01/15/01
Nael Hajjar BRD	Director/Board Member	40	01/18/01
John Bitar BRD	Director/Board Member	62	06/20/06

	Vote	Quantity	Free-Float	Total Float
Stock A	0	100,000	0	97.94 %
Stock B	1	9,056,271	8,869,654 ( 97.94 %)
Stock C	0	193,730	0

Name	Equities	%	Valuation
Michael Bigger 4.201 %	361,000	4.201 %	2 M $
Antonios Isaac 1.071 %	92,000	1.071 %	433 320 $
Virland Johnson 0.9148 %	78,617	0.9148 %	370 286 $
Vanguard Group, Inc. (Subfiler) 0.8530 %	73,304	0.8530 %	345 262 $
TD Waterhouse Canada, Inc. 0.3695 %	31,750	0.3695 %	149 543 $
LPL Financial LLC 0.2033 %	17,474	0.2033 %	82 303 $
STATE STREET CORPORATION 0.1860 %	15,980	0.1860 %	75 266 $
Geode Capital Management LLC 0.1701 %	14,617	0.1701 %	68 846 $
Richard Butler 0.1629 %	14,000	0.1629 %	65 940 $
Morgan Stanley Smith Barney LLC 0.1164 %	10,000	0.1164 %	47 100 $

Name	Equities	%	Valuation
Greenfield Investments Ltd. 47.73 %	137,730	47.73 %	648 708 $

Name	Equities	%	Valuation
Amol Soin 100.00 %	100,000	100.00 %	471 000 $

JanOne, Inc.

325 East Warm Springs Road Suite 102

89119-4238, Las Vegas

+702 997 5968

http://www.janone.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
JANONE INC.	+510.81%	30.7M
MODERNA, INC.	+33.63%	50.93B
IQVIA HOLDINGS INC.	-0.09%	42.12B
LONZA GROUP AG	+49.62%	42.05B
CELLTRION, INC.	-4.96%	29.18B
ICON PUBLIC LIMITED COMPANY	+11.18%	26.02B
ALNYLAM PHARMACEUTICALS, INC.	-21.95%	18.9B
BIO-TECHNE CORPORATION	+8.61%	13.21B
UNITED THERAPEUTICS CORPORATION	+24.73%	12.17B
MEDPACE HOLDINGS, INC.	+28.31%	12.16B

Other Biotechnology & Medical Research